AZ3146

SynDRA canonical compound SYN1970343 — structure-anchored drug synonym record

Clinical phase	Preclinical
Mechanism of action	monopolar spindle 1 kinase inhibitor

Mechanisms of action (all sources)

AZ-3146
9-cyclopentyl-2-(2-methoxy-4-(1-methylpiperidin-4-yloxy)phenylamino)-7-methyl-7H-purin-8(9H)-one
CHEMBL2140523
9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one
9-cyclopentyl-2-[2-methoxy-4-(1-methylpiperidin-4-yl)oxyanilino]-7-methylpurin-8-one
9-cyclopentyl-2-({2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]phenyl}amino)-7-methylpurin-8-one
9-cyclopentyl-2-((2-methoxy-4-((1-methylpiperidin-4-yl)oxy)phenyl)amino)-7-methyl-7H-purin-8(9H)-one
AU5
MLS006011199
GTPL9400
SCHEMBL1782786
DTXSID20719960
EX-A440
HMS3656H19
BCP02545
BDBM50446445
MFCD18384959
s2731
ZINC73096242
AKOS024457919
BCP9000349
CCG-264989
CS-0883
NCGC00263090-01
9-Cyclopentyl-7,9-dihydro-2-[[2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]phenyl]amino]-7-methyl-8H-purin-8-one
AC-27407
AS-16826
DA-35315
HY-14710
SMR004702968
AZ3146, >=98% (HPLC)
FT-0752560
SW219317-1
A894588
J-002776
J-519504
Q27458077
9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one;AZ3146
9-Cyclopentyl-2-{2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]anilino}-7-methyl-7,9-dihydro-8H-purin-8-one